Average peak sales forecast per new biopharmaceutical asset 2013-2024

Published by
Matej Mikulic
,
May 2, 2025

This statistic shows the projected average peak sales per new pharmaceutical pipeline asset from 2013 to 2024, in million U.S. dollars. The projected average peak sales per new asset dropped from 555 million U.S. dollars in 2017 to 353 million U.S. dollars in 2023. The latest year, however, showed a recovery up to 510 million U.S. dollars.

Projected average peak sales for each new biopharmaceutical asset from 2013 to 2024 (in million U.S. dollars)

CharacteristicSales in million U.S. dollars
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Showing entries 1 to 12 (12 entries in total)
Statistic: Projected average peak sales for each new biopharmaceutical asset from 2013 to 2024 (in million U.S. dollars)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2025

Region

Worldwide

Survey time period

2013 to 2024

Special properties

Top 20 biopharma companies by R&D spend

Supplementary notes

The statistic includes a combined cohort of biopharma companies with the largest R&D spending.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical research and development "

Other statistics that may interest you Pharmaceutical research and development

Overview

6

R&D performance by company

5

Characteristics of R&D pipeline

5

Duration, cost and ROI

4

Outsourced R&D

6

Public opinion/knowledge

5

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical research and development (R&D)Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.